Global Cervical Cancer Diagnostics and Therapeutic Market - Segmented by diagnostic test, method, end user, therapy and geography (2016 - 2021)

  • ID: 3784692
  • Report
  • Region: Global
  • 129 pages
  • Mordor Intelligence
1 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • Advaxis Immunotherapies
  • Bionor Pharma
  • Dendreon Corporation
  • GlaxoSmithKline PLC
  • Merck
  • MORE
The global cervical cancer market was valued at USD 2,140 million in 2015 and is expected to grow at a CAGR of 2-5% during 2015 to 2020.

Cervical cancer is generally characterized by the abnormal growth of cancerous cells in the tissues of the cervix, and it may manifest itself as a squamous-cell carcinoma or adenocarcinoma. According to the World Health Organization (WHO), cervical cancer accounts for the deaths of more than 270,000 women annually, primarily in the developing countries. With the increasing use of cervical cancer diagnostic tests such as pap smear tests, HPV testing and colposcopy for early detection, the market is highly competitive, with high growth rate.

The advent of technologically advanced computer-guided screening tests for cervical cancer, in order to reduce the rate of false-negative results, and improved accuracy are expected to contribute to the growth of the cervical cancer diagnostic tests market during the forecast period, from 2014 to 2020.

The global cervical cancer diagnostic and therapeutic market is segmented on the basis of:

- Diagnostics test
- Pap smear test
- HPV testing
- Colposcopy
- Cervical cancer biopsy
- Others
- Methods
- Molecular method
- Cytopathological method
- Physical method
- Users
- Hospitals
- Laboratories
- Independent physicians
- Clinics
- Others
- Therapies
- Surgery
- Radiation therapy
- Chemotherapy
- Others
- Geographical Region
- North America
- Asia-Pacific
- Europe
- Rest of the world

North Americas is expected to account for almost 49% of the total market share by 2020.

Some of the key players of cervical cancer diagnostics and therapeutics market are Abbott diagnostics, Becton Deckinson and company, Roche, Siemens Healthcare, Autogenomics, Biolight meditech, Cooper surgical, cancer genetics, EDP Biotech, Companion DX, Genomic tree, Metabiomics, Exact sciences etc.

Drivers:

- Rising prevalence of cervical cancer
- Favourable government initiatives
- Funding to increase disease awareness
- Increase of pipeline cervical cancer screening tests
- Aging population
- Increasing consumer awareness

Restraints:

- Cost of screening test
- Availability of HPV vaccines
- Uncertain reimbursement rates
- Changes in regulatory guidelines

Please note: As this product is updated at the time of order, dispatch will be 72 hours from the date the order and full payment is received
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • Advaxis Immunotherapies
  • Bionor Pharma
  • Dendreon Corporation
  • GlaxoSmithKline PLC
  • Merck
  • MORE
1 Introduction
1.1 Report Description
1.2 Research Methodology
2 Executive summary
3. Market overview
3.1 Market definition
3.2 Market drivers
3.2.1 Increase of Pipeline Colorectal Cancer Screening Tests
3.2.2 Aging Population
3.2.3 Increasing Consumer Awareness
3.3 Market restraints
3.3.1 screening test costs
3.3.2 Counseling
3.4 Market opportunities
4. Portors five force analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of comprtition
4.4 Threat of substitution
4.5 Threat of new entrants
5. Market segmentation
5.1 By diagnosis
5.1.2 Digital Rectal Examination
5.1.3 Fecal Occult Blood Test
5.1.4 Flexible Sigmoidoscopy
5.1.5 Colonoscopy
5.1.6 Virtual Colonoscopy
5.2 By treatment
5.2.1 Surgery and Radiation Therapy
5.2.2 Chemotherapy
5.2.3 Targeted Therapies
5.2.4 Resistance to Pharmacological Therapies
5.3 By geography
5.3.1 middle east and africa
5.3.1.1 Qatar
5.3.1.2 Saudi Arabia
5.3.1.3 South Africa
6.Competitive Landscape
6.1 Mergers & Acquisitions
6.2 Agreements, Partnerships and Collaborations
6.3 New Product Launches
6.4 Recommendations to new market players
7. Company profiles
7.1 Abbott Diagnostics
7.2 Alere
7.3 Beckman Coulter
7.4 Clinical Genomics
7.5 Companion Dx
7.6 EDP Biotech
7.7 Epigenomics AG
7.8 Exact Sciences
7.9 Fujirebio (Miraca Holdings)
7.10 Genomic Tree
7.11 Metabiomics
7.12 Oncocyte (Biotime)
7.13 Quest Diagnostics
7.14 Randox Laboratories
7.15 Siemens Healthcare
7.16 Volition Rx
8Appendix
8.1 Abbreviations
8.2 Sources
8.3 Bibliography
8.4 Disclaimer
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Diagnostics
  • Becton Deckinson and Company
  • Roche
  • Qiagen
  • Siemens Healthcare
  • Dendreon Corporation
  • Otsuka Pharmaceuticals
  • Merck
  • GlaxoSmithKline PLC
  • Advaxis Immunotherapies
  • Bionor Pharma
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll